Anesthesia and the hepatobiliary system
This presentation is the property of its rightful owner.
Sponsored Links
1 / 35

Anesthesia and the HepatoBiliary System PowerPoint PPT Presentation


  • 137 Views
  • Uploaded on
  • Presentation posted in: General

Anesthesia and the HepatoBiliary System. Gurdip Bhatia, MD Charles E. Smith, MD MetroHealth Medical Center Case Western Reserve University Cleveland, Ohio March 30, 2004. Objectives. Hepatic Physiology Mechanisms of Hepatocellular Injury Acute Parenchymal Liver Disease

Download Presentation

Anesthesia and the HepatoBiliary System

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Anesthesia and the hepatobiliary system

Anesthesia and the HepatoBiliary System

Gurdip Bhatia, MD

Charles E. Smith, MD

MetroHealth Medical Center

Case Western Reserve University

Cleveland, Ohio

March 30, 2004


Objectives

Objectives

  • Hepatic Physiology

    • Mechanisms of Hepatocellular Injury

  • Acute Parenchymal Liver Disease

    • Assessment of Liver Function

    • Preoperative Considerations

    • Intraoperative Considerations


Objectives1

Objectives

  • Chronic Parenchymal Liver Disease

    • Preoperative Considerations

    • Intraoperative Considerations

  • Postoperative Liver Dysfunction

    • Anesthetic Considerations


Hepatic physiology

Hepatic Physiology

  • Liver Blood Flow

  • 25% of Cardiac output

  • Hepatic artery ~25% of blood flow

  • Portal vein ~ 75% of blood flow

  • Hepatic Veins empty into the inferior vena cava


Splanchnic circulation fig 17 1

Splanchnic Circulation Fig 17.1


Hepatic microcirculation

Hepatic Microcirculation

  • Portal Axis consists of a terminal portal venule, a hepatic arteriole and a bile ductule

  • Liver Acinusfunctional microvascular unit

    • Zone 1- rich in Oxygen, mitochondria

      • Oxidative metabolism, synthesis of glycogen

    • Zone 2- transition

    • Zone 3- lowest in Oxygen, anaerobic metabolism, Cytochrome P-450

      • Biotransformation of drugs, chemicals, and toxins

      • Most sensitive to damage due to ischemia, hypoxia, congestion


Microvascular structure fig 17 3

Microvascular Structure Fig 17.3


Regulation of liver blood flow

Regulation of Liver Blood Flow

  • Intrinsic Regulation

    • Autoregulation

    • Metabolic control

    • Hepatic Arterial Buffer Response

      • Decreases in portal blood flow causes increased hepatic arterial blood flow

    • Extrinsic Regulation

      • Neural Control

      • Hormones

      • Effects of Anesthesia


Regulation of liver blood flow1

Regulation of Liver Blood Flow

  • Individual anesthetics

  • Isoflurane and Sevoflurane preserve Hepatic blood flow

  • Upper Abdominal Surgery

    • Hepatic blood flow reduced by 60 %

  • Regional Subarachnoid Block of T4

    • Reduces 20% of Hepatic blood flow


Functions of the liver i

Functions of the Liver - I

  • Metabolic

    • Protein: Albumin major protein, Coagulation factors except Factor VIII

    • Carbohydrates: Glucose homeostasis via gluconeogenesis and glycogenolysis

    • Lipids: Degraded to Acetylcoenzyme, a key molecule in synthesis of ATP, Cholesterol and Phospholipids


Functions of the liver ii

Functions of the Liver-II

  • Bilirubin conjugation and secretion

  • Bile formation

  • Hematologic function

    • Hematopoiesis 9th to 24th week gestation

  • Clears Fibrin Degradation Products and Lactate

    • Important in shock and massive blood loss and transfusion


Functions of the liver iii

Functions of the Liver-III

  • Humoral function

    • Insulin degraded 50% in the first pass

    • T4 to T3 conversion

    • Aldosterone, estrogen, androgen, ADH all are inactivated by the liver

    • Liver disease thus, results in endocrine abnormalities

  • Immunologic function

    • Kupffer cells phagocytose antigens


Functions of the liver iv

Functions of the Liver-IV

  • Drug Biotransformation

    • Make drugs more polar for efficient elimination

    • Phase I Reaction

      • Cytochrome P450 system

      • Oxidation/reduction

      • Mixed –Function Oxidases

    • Phase II Reaction

      • Conjugation most commonly catalyzed by UDP-glucuronyl transferase


Factors affecting hepatic drug metabolism

Factors Affecting Hepatic Drug Metabolism

  • Drugs with high extraction ratio are affected more by changes in HBF

    • Propranolol, Lidocaine, Meperedine

  • Poorly extracted drugs are more sensitive to intrinsic ability of the liver to eliminate a drug

    • Diazepam, Phenytoin, Coumadin

  • Anesthesia

    • Ketamine induces its own metabolism, therefore rapid tolerance can occur


Evaluation of liver function

Evaluation of Liver Function

  • Laboratory Tests:

    • ALT, AST, Alkaline phosphatase with 5’-nucleotidase

    • Serum Albumin, Gamma-globulin

    • PT (best estimate of hepatic function)

    • Antinuclear Antibody

      • Chronic Active Hepatitis 75%

    • Antimitochondrial antibody

      • Primary biliary cirrhosis 100%

  • Radiologic Techniques

    • Cholangiography, Radionuclide and Ultra sound


Acute viral hepatitis

Acute Viral Hepatitis

  • Postpone elective surgery

  • High mortality and morbidity

  • Acute encephalopathy, avoid premed sedatives

  • Frequent blood glucose monitoring for hypoglycemia

  • Correction of Coagulopathy with Vit K, FFP and platelet transfusion


Algorithm for abnormal transaminase levels fig 54 1a

Algorithm for Abnormal Transaminase levels fig 54-1A


Algorithm for abnormal transaminase levels fig 54 1b

Algorithm for Abnormal Transaminase levels fig 54-1B


Algorithm for abnormal transaminase levels fig 54 1c

Algorithm for Abnormal Transaminase levels fig 54-1C


Chronic liver disease or cirrhosis preop considerations

Chronic Liver Diseaseor Cirrhosis PreOp considerations

  • Portal hypertension may lead to GI hemorrhage

  • Rx Fluid resuscitation

    • Must be done carefully to avoid rebleeding of varices

    • Vasopressin and Octreotide constrict splanchnic arteriolar bed


Chronic liver disease preop

Chronic Liver Disease PreOp

  • Ascites is due to portal hypertension and sodium retention that occurs with cirrhosis

  • Rx with Sodium and water restriction and diuretics

  • Diuretics

    • Cause hyponatremia and hyperkalemia

    • Check and correct electrolytes


Chronic liver disease preop1

Chronic Liver Disease /PreOp

  • Paracentesis of Ascites

    • Not exceed 1 Liter/day for a daily weight loss of 0.5 to 1.0 kg

    • 1 liter of ascites fluid contains 10 grams of Albumin

    • Each liter of ascites removed must be replaced by 50 ml of 25% Albumin


Chronic liver disease preop2

Chronic Liver Disease /PreOp

  • Hepatorenal syndrome can be precipitated

    • By aggressive paracentesis, potent diuretics like Zaroxolyn

    • Avoid aminoglycosides (contraindicated), NSAIDS, renal contrast, volume depletion

  • Hepatic Encephalopathy

    • Dysarthria, flapping tremor, hyperreflexia

    • Avoid long acting benzodiazepines, high dose opiates and diuretics


Chronic liver disease preop3

Chronic Liver Disease /PreOp

  • Child-Turcotte-Pugh Classification

  • Lab and clinical criteria to predict operative survival in patients with Cirrhosis

  • Class C, Surgical risk of Mortality rate 50%

    • Serum bilirubin > 3 mg/dl

    • Albumin < 3 g/dl

    • PT > 6 sec of control

    • Ascites uncontrolled, encephalopathy advanced, nutrition poor


Chronic liver disease intraop

Chronic Liver Disease /IntraOp

  • Optimum drugs or techniques are unknown

  • Avoid or reduce dose of drugs excreted via the liver such as Lidocaine, Meperidine, Morphine

  • Succinylcholine acceptable, effects are not prolonged significantly

  • NDMB may have prolonged duration of action

    • Atracurium may be better as it is eliminated by Hoffman elimination

    • Vecuronium < 0.6 mg/kg, Atracurium < 0.15 mg/kg

    • Avoid Pancuronium


Chronic liver disease intraop1

Chronic Liver Disease/IntraOp

  • Most IV induction agents are metabolized by the liver but recovery depends on redistribution. Safe to use Propofol, Thiopental

  • For Inhalational agents, Isoflurane and Sevoflurane are better than Halothane as Hepatic Blood Flow is decreased to a lesser degree

  • Fentanyl and Sufentanil single dose bolus does not change elimination half life

  • Remifentanil is a safer choice as it is degraded by tissue and RBC Esterases


Chronic liver disease intraop2

Chronic Liver Disease/IntraOp

  • Laparotomy with Abdominal Paracentesis of Ascites

    • Maintain Intravascular volume,

    • Rx with Albumin

  • Patients with GI hemorrhage

    • Receiving blood products may have decreased clearance of Citrate which can lead to hypocalcemia

  • Bleeding diathesis

    • Rx with FFP or Prothrombin complex to correct PT within 3 secs of normal

    • Transfuse if platelets < 100,000/uL, Rx with DDAVP


Postop complications

PostOp Complications

  • Reversible minor changes are common

  • PostOp Jaundice may be due to hemolysis of transfused blood

  • Shock Liver syndrome can occur if prolonged hypotension persisted

    • Marked by severe hepato-cellular necrosis

    • SerumTransaminases levels increased > 10 fold

  • Bleeding, Sepsis, Renal failure


Summary i

Summary-I

  • Liver functions include

    • Protein synthesis

    • Drugs, fat and hormone metabolism

    • Immunologic function

    • Bilirubin formation and excretion

    • Glucose homeostasis


Summary ii

Summary-II

  • For Acute Hepatitis

    • Postpone all elective procedures as the mortality rate is very high

  • For unexpected high Transaminase levels

    • Repeat LFTs, if stable or decreasing may proceed with surgery

    • Otherwise GI consult should be obtained


Summary iii

Summary-III

  • In Chronic Liver disease pre-op issues include

    • GI hemorrhage

    • Ascites, electrolyte imbalances

    • Hypoglycemia,

    • Coagulopathy and bleeding disorder


Summary iv

Summary-IV

  • In Chronic liver disease intra-operatively

    • Avoid or reduce drugs that are eliminated by liver

    • IV inductions agents are considered safe

    • Inhalational agents

      • Use Isoflurane, avoid Halothane

      • Avoid Sevoflurane if risk of Hepato-Renal Syndrome

    • Muscle Relaxants all are acceptable

      • Vecuronium and Rocuronium have increased duration of action


Summary v

Summary-V

  • In Chronic liver disease intra-operatively

    • Opioids can be used

    • Maintain Intravascular volume

    • Consider replacing 50 mL of 25% Albumin for each liter of ascites fluid removed

    • Blood products can cause hypocalcemia and Calcium need to be replaced


Summary vi

Summary-VI

  • Post-Op Liver dysfunctions

    • Reversible minor changes are common

    • Post op Jaundice may be due to hemolysis, but other causes should be sought

    • Shock Liver syndrome presented by hepatocellular necrosis can occur due to prolonged hypotension


References

References

  • Anesthesia, Fifth Edition/ Ronald D. Miller, Hepatic Physiology, Chapter 17 & Anesthesia and the Hepatobiliary System, Chapter 54.

  • Anesthesia and Co-Existing Disease, Fourth Edition/ Robert K Stoelting, Stephen F. Dierdorf, Diseases of the Liver and Biliary Tract, Chapter 18.

  • Clinical Anesthesia, Fourth Edition/ Paul G. Barash, et.al., Anesthesia and the Liver, Chapter 39


  • Login